Our PharmaForce 2013 Speakers Include:

Ann Bartlett is an expert in balancing traditional, non-traditional, and lifestyle health choices to manage her own health. She has been a practicing massage therapist for 24 years for clients ranging from terminally ill to professional and world-class athletes and is owner of the Body in Balance Center, an integrated wellness practice in Alexandria, VA. Ms. Bartlett has lived with juvenile diabetes since she was 5 years old. Her father was a founding board member of JDRF. A pilot for TWA, he used his international travels to find Type 1 researchers from around the globe and engage them in collaborative sharing. He successfully fostered relationships in London, TeleViv and Milan and helped create the first international Type 1 diabetes symposium in the mid 70s. As a result of her parents’ efforts, Ann developed a sense of responsibility for her diabetes care and a love for understanding the body in health and illness. Ann sees the challenges of living with diabetes as a gigantic puzzle for which lifestyle, management and research give clues for fitting the pieces together and keeping her engaged in her long-term health and happiness. Ann is a former board member of JDRF Capitol Chapter having served 6 years as outreach chair and research information volunteer. Ann has been a patient expert for healthcentral.com for 4 years and served as the community leader for type 1 diabetes on healthcentral.com. Ann has been speaking at healthcare industry conferences and patient conferences. Ann also serves as a consultant for Sanofi US diabetes.

Philippe Barzin is Director, Strategic Business Planning & Execution for Johnson & Johnson Research & Development. In this capacity, Philippe supports strategic initiatives to improve patient safety, and all medical and operational aspects of pharmacovigilance globally. Philippe brings over 20 years of global experience in Pharma Marketing and Business Development with increasing roles of responsibility from such companies as Eli Lilly, Novo-Nordisk, Immunomedics and Bench International. Through his tenure in these companies, Philippe gained expertise in a number of therapeutic sectors such as oncology, immunology, diabetes care, and medical devices and diagnostics. With Immunomedics in particular, Philippe acted as managing director, Europe and vice-president of global business development. He created their BioPharm European affiliate from scratch building a multi-million dollar organization and secured many multi-million dollar long-term deals. Philippe graduated Magna Cum Laude (1st in his class) with a Master’s of Science degree from the University of Liege, majoring in Histology, Physiology and Biochemistry. Philippe earned his Six Sigma Black Belt Certification and completed his Master Black Belt Training with Johnson & Johnson. He is also the recipient of four Standards of Leadership Awards within Johnson & Johnson.

Mike Capaldi is Associate Vice President, Civic Action & Social Networking for Sanofi US in his 16^th year with the organization. He is responsible for encouraging civic action and employee engagement throughout the organization. This includes leading the grassroots platform, employee PAC and other civic action programs. Mike also collaborates with appropriate trade associations and external stakeholders for important industry issues. He is also leading an emerging effort to channel the power of social media to champion key issues as it has become an increasingly influential medium. Mike’s experiences include work in Corporate Social Responsibility and Training & Development for 12 years where he was responsible for the T&D of nearly 10,000 field and headquarter-based employees. Mike served as President of the Society of Pharmaceutical and Biotech Trainers in 2010-11.

Kim has 18 years in the biopharma industry with experience in instructional design, developing interactive training initiatives and implementation of technology-based learning methodology to achieve sales force and business goals. She has significant background in sales leadership, project management, product launch experience – including sales force expansion and pre-market development - as well as in building an educational platform to support commercial team success.

Abhiroop Gandhi is Compliance Officer at Questcor Pharmaceuticals. He is responsible for implementing and managing the company’s corporate ethics and healthcare compliance program and is based in the San Francisco Bay Area. This program includes development, implementation and oversight of compliance policies and procedures, employee training, audits, monitoring, incident management & investigations, transparency initiatives and providing day-to-day advice to business partners. Prior to joining Actelion, Mr. Gandhi was the Director of Commercial Compliance at Actelion Pharmaceuticals, Inc., where he established and managed the healthcare compliance program. Previously, he was at Genentech in the Commercial Business Practices group, where he was involved with initiating and managing various cross-functional compliance and commercialization initiatives. Prior to Genentech, Mr. Gandhi was a management consultant with Razorfish and advised clients in the life sciences and high-tech industries. Abhiroop holds a Master’s degree from Carnegie Mellon University, an MBA from FMS, Delhi University and a Bachelor of Engineering (Mechanical) from Birla Institute of Technology.

Ms. Giordano has been Chief Executive Officer, President and Director of Xanodyne Pharmaceuticals, Inc. a branded specialty pharmaceutical company with commercial and development capabilities focused on pain management, since May 2010 and Chief Operating Officer since 2009. She presently serves as director on the boards of Aceto Corporation [NASDAQ:/ACET] and ClearPoint Interactive Health Education [privately held]. Prior to 2009, she functioned as President, Americas for Cegedim Dendrite (formerly Dendrite International Inc.) from 2007 to 2008 and as Senior Vice President of the Global Customer Business Unit of Cegedim Dendrite from 2004 to 2007. She has been with Cegedim Dendrite since 2000 and served as Group President for Global Business Unit for major customers, and Vice President of Global Sales. Earlier in her career, she worked nine years with Parke-Davis then owned by Warner Lambert in several sales and marketing positions including Strategic Alliance management and Sales Integration. Ms. Giordano holds a Bachelors of Science degree from Wagner College in New York and is a Registered Nurse.

Michael Hirsch is the Senior Director of Market Access at Cubist Pharmaceuticals based in Lexington, MA. He leads a 30 person Market Access department specializing in acute care, outpatient therapy and National/IDN account management. In addition, Michael has responsibility for pricing strategy, healthcare policy, and patient assistance. Prior to Cubist, Michael worked in a specialty sales environment focused on biologics and vaccines.

With over eight years in the healthcare sector, Nancy began her pharmaceutical career at Eli Lilly & Company in neuroscience specialty sales while attending business school in Southern California. Post graduation, she transferred from the field to corporate headquarters to work in a strategic capacity on the Cymbalta® brand team. During that rotation, she worked to develop new indication strategies for the US marketplace. She also held a medical marketing role on the Cymbalta® brand team before choosing to move back to California. At Amgen, Nancy launched XGEVA® in the US oncology marketplace, working on both disease state education and branded campaigns. Currently, she is a senior marketing manager on the global oncology marketing team, with international responsibilities for both XGEVA® and a new phase three melanoma asset, T-VEC.

Mr. Kukla joined Purdue Pharma L.P. as a Sales Representative in Syracuse, New York in May 1983. During his tenure in the Field Sales group, Tom achieved the following positions: District Field Trainer, Senior Medical Marketing Representative, Product Specialist (1989-1991), and membership in Purdue’s elite TOPPERs Club. Tom was promoted to District Manager and, under his Leadership, the Syracuse District achieved consistent sales growth and six Syracuse Sales Representatives were promoted to District Managers and Home Office positions. In July 1998, Mr. Kukla was promoted to Purdue’s Home Office to build and lead the newly created Field Management Development Group. Mr. Kukla currently holds the position of Senior Director, Field Management Development and is a member of a Core Business Executive Team. Tom recently developed and coordinated the Leadership Development curriculum for Sales Management, the DM Advisory Council, and Sales and Marketing. Earlier this year Mr. Kukla coordinated the Launch Meeting for Purdue’s newest product. In his current position, Tom works directly with Sales Management, Sales Training, Sales Operations, Compliance, and Marketing, Mr. Kukla holds a Degree in Biology from the SUNY at Oswego.

Pharmaguy (@pharmaguy) – also known as John Mack – is the Publisher and Editor of Pharma Marketing News, an independent monthly electronic newsletter focused on issues of importance to pharmaceutical marketing executives. Previously, Mr. Mack was a consultant in the Life Sciences Practice at Answerthink, where he managed projects such as pharmaceutical direct-to-consumer marketing and physician web site development, privacy policy assessments, and HIPAA awareness workshops. Mr. Mack also owned and managed PharmInfoNet, a "Top 20 Health Site" focused on drug information content and databases for physicians and pharmacists. In 1999, he sold this web site to Mediconsult and became its Director of Drug Information. Mr. Mack is an accomplished blogger. In January 2005, he created Pharma Marketing Blog (www.pharmamarketingblog.com), which focuses on commentary about topical pharmaceutical marketing issues. Pharma Marketing Blog was cited by the Wall Street Journal as a blog “insiders read to stay current” and by MedAdNews as "...often-entertaining, always informative..."

Harley is the co-author of Outside In: The Power of Putting Your Customers at the Center of Your Business. He launched the customer experience practice at Forrester Research and has led it for 14 years. Forrester’s customer experience research team covers topics ranging from voice of the customer programs to modeling the return on investment from customer experience projects. Harley's personal coverage areas include interaction design, online branding, persona development, design agencies, and user experience reviews. Harley came to Forrester in 1998 after spending 18 years designing and building interactive services for companies such as Dow Jones, AT&T, MCI, Prodigy, and Sears. Most recently, he was at Dow Jones Markets, where he was responsible for international websites targeted at brokers and traders. He was also responsible for the design, hosting, and operation of the Markets' intranet site, which later became the intranet site for all of Dow Jones. Prior to Dow Jones, Harley was at AT&T Labs, where he designed the user experience for projects such as a search engine enhanced with ontologies (two patents awarded), a universal email/telephone/fax message center, and a web-based community calendar. He originally joined AT&T as the creative director of its personal online services group. Harley holds a Master of Science degree in advertising from the University of Illinois, Urbana.

With more than 19 years of service at CMR Institute, Michelle O’Connor has overseen most every aspect of the organization’s contributions to providing healthcare education to the biopharmaceutical industry. Ms. O’Connor’s extensive background in education and healthcare has helped to shape her vision for the company. She has been instrumental in the development and evolution of CMR’s product development, to e-learning and mobile delivery of its educational content to improving learning outcomes for client organizations. She is focused on meeting tomorrow’s educational needs of the biopharmaceutical and other medical device and diagnostics industries which has expanded CMR Institute from being a niche certification provider to an innovative learning company during the industry’s most challenging economic era. Ms. O’Connor received an M.A. in education from Virginia Tech in Curriculum and Instruction with an emphasis in Training and Development.

President, Center for Medicine in the Public Interest
Advisor to Obama Administration FDA Transition Team
Former Associate Commissioner, US Food and Drug Administration

• Special Government Employee, FDA Risk Communications Advisory Committee
• Board of Advisors, Digital Health Council
• Editorial Advisory Board, Food and Drug Policy Forum
• Board of Advisors, New York State Health Foundation
• Washington Drug Letter, Editorial Advisory Board
• Briefings on Drug Safety, Editorial Advisory Board
• Advisory Board, Pharmaceutical Executive Magazine
• Advisory Board, MedAd News
• Editorial Advisory Board, The Patient Magazine
• Associate Editor, Drug Information Journal
• Scientific Advisory Council. Animal Health Institute

Peter Pitts is President of the Center for Medicine in the Public Interest. From 2002-2004 A former member of the United States Senior Executive Service, Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He supervised FDA's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management. He served on the agency’s obesity working group and counterfeit drug taskforce and is a Special Government Employee (SGE) consultant to the FDA’s Risk Communications Advisory Committee where he is advising the FDA on regulatory issues in the sphere of social media. Specific areas of global policy expertise include food safety and security, recalls, nutritional labeling, genetically modified food issues, drug safety, reimbursement policy, EBM/HST, DTC/ItP, Critical Path, Personalized Medicine, Clinical Trial Transparency, IP Protection, FDA Reform, Drug Importation, Counterfeiting.

In 2010, he was named by Modern Healthcare magazine as one of the 300 “most powerful people in American healthcare.” His comments and commentaries on health care policy issues regularly appear in The New York Times, The Los Angeles Times, The Washington Post, The Wall Street Journal, The Financial Times, Health Affairs, The Boston Globe, The Washington Times, The Chicago Tribune, The Chicago Sun Times, The San Francisco Examiner, Investor’s Business Daily, The Baltimore Sun, The Economist, Nature Biotechnology, The Journal of Life Sciences the BBC World Service, Fox News, and The NewsHour with Jim Lehrer, among others. His book, Become Strategic or Die, is widely recognized as a cutting edge study of how leadership, in order to be successful over the long term, must be combined with strategic vision and ethical practice. He is the editor of Coincidence or Crisis, a discussion of global prescription medicine counterfeiting and Physician Disempowerment: A Transatlantic Malaise. He has served as an adjunct professor at Indiana University’s School of Public and Environmental Affairs and Butler University. A graduate of McGill University, he is married to Jane Mogel, and has two sons.

Eric started his sales and marketing career 20 years ago at TAP Pharmaceuticals after 4 years in the US Army as an infantry officer. He is now at Watson Pharmaceuticals where he is a Director of Marketing for both urology and the digital communication for all of Watson’s branded products. Over his career, he has acted in almost every role in sales, marketing, training and advertising for various pharmaceutical and biotech companies. Eric is also an active volunteer firefighter in his hometown of Moorestown, New Jersey where he lives with his wife and 3 children.

Aaron has been in the pharmaceutical industry for the past six years and served as an officer in the military prior to this. His career with Sanofi began in field sales, where he worked in various capacities, before entering his current role in Closed Loop Marketing. He is also currently pursuing his MBA through the University of North Carolina-Chapel Hill.

Charlotte is currently President, Sibley Associates, a pharmaceutical and biotech consulting firm. She serves on the Board of Directors of American Pacific Corporation (AMPAC), a leading custom manufacturer of fine chemicals, specialty chemicals, and propulsion products. Additional Board positions include MindField Solutions, which uses neuroscience tools to improve healthcare decision-making and Galileo Analytics, a leader in the field of claims data analysis. Supporting advances in her field, Charlotte serves on the Executive Committee of the Marketing Research Institute International and the Corporate Healthcare Businesswomen’s Association (HBA) Board. Recognized for her leadership and mentoring, Charlotte was named the HBA 2008 Woman of the Year. She was selected as one of the most Inspiring People in Pharma in 2006, and was awarded the 2001 R.R. Fordyce Award for ethics and excellence in marketing research.

Charlotte is an Adjunct Professor at Columbia University Graduate School of Business and serves on the Advisory Board for the St. Joseph’s University Healthcare Executive MBA program. She is also on the Pharmaceutical Executive Editorial Advisory Board. Charlotte has built and led integrated marketing research, competitive intelligence, strategic forecasting and decision science groups in 6 major pharmaceutical and biotech companies. She established and led the U.S. business for Isis Research Ltd., a global healthcare marketing research firm. Most recently, she was at Shire plc. as Senior Vice President, Business Management, with responsibility for cross-functional corporate initiatives. Her career has spanned over 30 years in the healthcare industry, starting in market research at Pfizer. Charlotte worked for Johnson & Johnson, Bristol-Myers Squibb, and Lipton in market research. She also spent 3 years on Wall Street at Donaldson, Lufkin & Jenrette as a security analyst for the pharmaceutical industry. She holds an MBA in Finance and Marketing from the University of Chicago Booth Graduate School of Business and an AB in French and German from Middlebury College. Charlotte and her husband Leif Magnusson, an attorney, and their two cats live in Berwyn, PA.

Todd N. Smith, Executive Vice President and Chief Commercial Officer Mr. Smith joined Horizon Pharma October 2010 and was named to his current position as executive vice president and chief commercial officer in June 2012. Mr. Smith is responsible for the company’s commercial organization, business development and investor relations. Prior to joining Horizon Pharma, Mr. Smith served as vice president, global marketing, strategy and business development at Fenwal Inc., a global medical device company formed through a TPG financed spin-off from Baxter. Mr. Smith was responsible for Fenwal’s global product portfolio, the company’s strategic planning and business development initiatives. During this time Fenwal launched over 10 products and reignited growth in its core automation businesses.

Todd has nearly 18 years of pharmaceutical and biotechnology industry experience, holding a succession of senior management roles in sales, marketing and business development at both top 20 pharma companies including Abbott and Bayer as well as ventured backed biotech’s including Agouron and Achillion. As a sales and marketing executive, Mr. Smith has either led or been part of over 12 product launches. He led both sales and marketing activities for the Virology Franchise at Abbott, including the launch of Kaletra tablets (a critical life cycle reformulation), where global sales grew to over $1 billion. In his business development roles he has structured licensing deals, joint ventures and managed alliances regionally and globally. He earned a bachelor's degree in political science from Norwich University